By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Implantable cardiac pacemakers, implantable cardioverter defibrillators (ICDs), biventricular pacemakers, and cardiac loop recorders are just a few of the cardiac electronic devices that can be placed inside the heart and used to monitor or control irregular heartbeats in people with certain heart rhythm disorders and heart failure.
Any device that is inserted into the arteries, veins, or the heart itself to treat, prevent, or manage a disease, injury, or other condition is referred to as a vascular medical device.
This vasculature includes the anatomy of the cardiovascular, peripheral, and neurovascular systems.
The Qatar Cardiovascular Medical Devices market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Launch of the WHO Priority Medical Devices List for Diabetes and Cardiovascular Disease Management Today’s release of the WHO List of Priority Medical Devices for the management of diabetes and cardiovascular diseases will aid policymakers and healthcare professionals in selecting and acquiring medical devices for these conditions in a more prioritized manner.
It includes more than 500 devices that are necessary at all levels of the healthcare system, from primary care facilities to highly specialized hospitals, as well as devices required for medical emergencies like cardiac arrest, stroke, and low or high blood sugar.
The new List offers clinical recommendations for particular conditions, outlines the necessary treatments (such as hospitalization, cardiac surgery, intensive care, laboratory testing, and medical imaging), and then lists all the necessary medical equipment, including surgical instrument sets, personal protective equipment, diagnostic and therapeutic devices, etc.
The ultimate goal of this new List is to assist healthcare professionals in putting interventions into place that are crucial for the detection and management of heart conditions and diabetes across the continuum of care, resulting in fewer hospitalizations and fatalities and the conservation of priceless medical resources.
More than 15 million people between the ages of 30 and 69 die prematurely each year as a result of non-communicable diseases (NCDs), which account for 74% of all annual deaths worldwide and include diabetes and cardiovascular disease.
85% of these preventable deaths occur in low- and middle-income countries, largely as a result of a lack of testing and monitoring tools required for NCD screening, diagnosis, and treatment.
